|
Eine Ebene nach oben |
Gruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 3
2022
Raghu, Ganesh; Mouded, Majd; Chambers, Daniel C.; Martinez, Fernando J.; Richeldi, Luca; Lancaster, Lisa H.; Hamblin, Mark J.; Gibson, Kevin F.; Rosas, Ivan O.; Prasse, Antje; Zhaon, Guolin; Serenko, Michael; Novikov, Natasha; McCurley, Amy; Bansal, Prashant; Stebbins, Christopher; Arefayene, Million; Ibebunjo, Stella; Violette, Shelia M.; Gallagher, Diana und Behr, Juergen
(2022):
A Phase IIb Randomized Clinical Study of an Anti-alpha(v)beta(6) Monoclonal Antibody in Idiopathic Pulmonary Fibrosis.
In: American Journal of Respiratory and Critical Care Medicine, Bd. 206, Nr. 9: S. 1128-1139
Maher, Toby M.; Brown, Kevin K.; Kreuter, Michael; Devaraj, Anand; Walsh, Simon L. F.; Lancaster, Lisa H.; Belloli, Elizabeth A.; Padilla, Maria; Behr, Jürgen; Goeldner, Rainer-Georg; Tetzlaff, Kay; Schlenker-Herceg, Rozsa und Flaherty, Kevin R.
(2022):
Effects of nintedanib by inclusion criteria for progression of interstitial lung disease.
In: European Respiratory Journal, Bd. 59, Nr. 2, 2004587
2019
Culver, Daniel A.; Behr, JOuergen; Belperio, John A.; Corte, Tamera J.; de Andrade, Joao A.; Flaherty, Kevin R.; Gulati, Mridu; Huie, Tristan J.; Lancaster, Lisa H.; Roman, Jesse; Ryerson, Christopher J. und Kim, Hyun J.
(2019):
Patient Registries in Idiopathic Pulmonary Fibrosis.
In: American Journal of Respiratory and Critical Care Medicine, Bd. 200, Nr. 2: S. 160-167